Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison.

[1]  P. Jüni,et al.  Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[2]  H. Katus,et al.  Improvements of Procedural Results With a New‐Generation Self‐Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old‐Generation Device , 2017, Journal of interventional cardiology.

[3]  R. Kornowski,et al.  Comparative Matched Outcome of Evolut-R vs CoreValve Transcatheter Aortic Valve Implantation. , 2017, The Journal of invasive cardiology.

[4]  T. Ando,et al.  Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: A meta-analysis. , 2016, International journal of cardiology.

[5]  S. Blankenberg,et al.  Improving outcomes: case-matched comparison of novel second-generation versus first-generation self-expandable transcatheter heart valves. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  J. Leipsic,et al.  One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis , 2016, Circulation.

[7]  C. Vahl,et al.  Transcatheter aortic valve implantation with the new-generation Evolut R™ , 2016, International Journal of Cardiology: Heart & Vasculature.

[8]  O. Alfieri,et al.  Usefulness of Predilation Before Transcatheter Aortic Valve Implantation. , 2016, The American journal of cardiology.

[9]  A. Colombo,et al.  Anaesthetic management of transcatheter aortic valve implantation: results from the Italian CoreValve registry. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  J. Leipsic,et al.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.

[11]  O. Alfieri,et al.  A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience. , 2016, The Journal of invasive cardiology.

[12]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[13]  J. Carroll,et al.  Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2015, Journal of the American College of Cardiology.

[14]  L. Räber,et al.  Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves , 2015, Circulation. Cardiovascular interventions.

[15]  W. Rottbauer,et al.  Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve. , 2015, International journal of cardiology.

[16]  I. Meredith,et al.  Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. , 2015, JACC. Cardiovascular interventions.

[17]  A. Colombo,et al.  5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis. , 2015, JACC. Cardiovascular interventions.

[18]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[19]  P. Stella,et al.  Transcatheter Aortic Valve Implantation With the New Balloon-Expandable Sapien 3 Versus Sapien XT Valve System: A Propensity Score–Matched Single-Center Comparison , 2015, Circulation. Cardiovascular interventions.

[20]  I. Meredith,et al.  Comparison of Self-Expanding and Mechanically Expanded Transcatheter Aortic Valve Prostheses. , 2015, JACC. Cardiovascular interventions.

[21]  K. Stangl,et al.  Optimal Implantation Depth and Adherence to Guidelines on Permanent Pacing to Improve the Results of Transcatheter Aortic Valve Replacement With the Medtronic CoreValve System: The CoreValve Prospective, International, Post-Market ADVANCE-II Study. , 2015, JACC. Cardiovascular interventions.

[22]  M. Mack,et al.  Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. , 2015, European heart journal.

[23]  M. Mack,et al.  Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. , 2014, Journal of the American College of Cardiology.

[24]  R. Lange,et al.  Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. , 2014, Journal of the American College of Cardiology.

[25]  Peter Jüni,et al.  Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. , 2014, Journal of the American College of Cardiology.

[26]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[27]  J. Mehilli,et al.  Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. , 2014, JAMA.

[28]  M. Mack,et al.  Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). , 2014, Journal of the American College of Cardiology.

[29]  K. Lachapelle,et al.  First-in-human experience with the Medtronic CoreValve Evolut R. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[30]  David H Adams,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[31]  J. Leipsic,et al.  Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  Susheel Kodali,et al.  Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement , 2013 .

[33]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[34]  A. Colombo,et al.  2-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access. , 2012, Journal of the American College of Cardiology.

[35]  P. Pibarot,et al.  Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. , 2012, JACC. Cardiovascular interventions.

[36]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[37]  F. Maisano,et al.  Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis , 2011, Circulation.

[38]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[39]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006, Circulation.

[40]  C. Lillehei,et al.  LEFT RETROGRADE CARDIOANGIOGRAPHY IN ACQUIRED CARDIAC DISEASE: TECHNIC, INDICATIONS AND INTERPRETATIONS IN 700 CASES. , 1964, The American journal of cardiology.